| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |